Article thumbnail

Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy

By Amy Fleischman and Erinn T Rhodes

Abstract

Childhood obesity has become a national and international epidemic. The prevalence and incidence of type 2 diabetes in youth have been increasing, and type 2 diabetes is one of the most challenging complications of obesity in childhood. Comprehensive lifestyle interventions that include attention to dietary change, increased physical activity and behavior change appear to be required for the successful treatment of pediatric obesity. In particular, aspects of behavioral interventions that have been identified as contributing to effectiveness have included intensity, parent/family participation, addressing healthy dietary change, promoting physical activity, and involving behavioral management principles such as goal setting. A multidisciplinary team approach is required for successful management of type 2 diabetes in youth as well. As with many therapies in pediatrics, clinical trials and support for treatments of obesity and type 2 diabetes in youth lag behind adult data. Pediatric recommendations may be extrapolated from adult data and are often based on consensus guidelines. Type 2 diabetes in children is most commonly managed with lifestyle modification and medications, metformin and/or insulin, the only medications currently approved for use in children. However, many opportunities exist for ongoing research to clarify optimal management for obesity and type 2 diabetes in youth

Topics: Review
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:3048003
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1992). A high incidence of type 1 diabetes and an alarming increase in the incidence of type 2 diabetes among young adults in Finland between
  2. A potential decline in life expectancy in the United States in the 21st century.
  3. (2008). A randomized-placebo controlled trial of the effects of metformin on body weight and body composition in children with insulin resistance (abstract). The Endocrine Society’s 90th Annual Meeting.
  4. (2003). A reduced-glycemic load diet in the treatment of adolescent obesity. Arch Pediatr Adolesc Med.
  5. (1997). A six-year follow-up study of smoking habits and microvascular complications in young adults with type 1 diabetes. Postgrad Med J.
  6. (2004). A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol.
  7. (2007). Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet.
  8. Addition of metformin to a lifestyle modification program in adolescents with insulin resistance.
  9. Addition of orlistat to conventional treatment in adolescents with severe obesity.
  10. Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls.
  11. (2005). Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area. Diabetes Care.
  12. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.
  13. (2009). Association Standards of medical care in diabetes –
  14. Association. Diabetes care in the school and day care setting. Diabetes Care. 2009;32 Suppl 1:S68–S72.
  15. Association. Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care.
  16. Autoimmunity and clinical course in children with type 1, type 2, and type 1.5 diabetes.
  17. (2007). Bariatric surgery in adolescents: recent national trends in use and in-hospital outcome. Arch Pediatr Adolesc Med.
  18. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial.
  19. (2002). Behavioral weight control for overweight adolescents initiated in primary care. Obes Res.
  20. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
  21. (2009). Best practice updates for pediatric/adolescent weight loss surgery. Obesity (Silver Spring).
  22. Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind, placebo-controlled study.
  23. (2009). Cardiovascular risk factors among youth with and without type 2 diabetes: differences and possible mechanisms. Diabetes Care.
  24. (2000). CDC Growth Charts: United States.
  25. (2003). Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care.
  26. Childhood obesity as a chronic disease: keeping the weight off.
  27. Childhood obesity: public-health crisis, common sense cure.
  28. Clinical review: treatment of pediatric obesity: a systematic review and meta-analysis of randomized trials.
  29. (2009). Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care.
  30. (2004). Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol.
  31. (2005). Depression and diabetes in children and adolescents. Curr Opin Pediatr.
  32. Diabetes in African American youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care.
  33. (2000). diabetes in children and adolescents. American Diabetes Association. Diabetes Care.
  34. Diabetes in Hispanic American youth: prevalence, incidence, demographics, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009;32 Suppl 2:S123–S132.
  35. Diabetes in non-Hispanic white youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care.
  36. (2008). diabetes mellitus in the child and adolescent. Pediatr Diabetes.
  37. (2008). Diabetes mellitus: considerations for dentistry. J Am Dent Assoc.
  38. Diabetic autoimmune markers in children and adolescents with type 2 diabetes.
  39. double-blind, placebo-controlled trial of orlistat for weight loss in adolescents.
  40. (1999). Early presentation of type 2 diabetes mellitus in young New Zealand Maori. Diabetes Res Clin Pract.
  41. (2002). Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care.
  42. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.
  43. (2008). Effectiveness of Weight Management Programs in Children and Adolescents. Evidence Report/Technology Assessment No.
  44. Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial.
  45. Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile.
  46. Effects of orlistat on fat-soluble vitamins in obese adolescents.
  47. (2008). Effects of resistance training on metabolic fitness in children and adolescents: a systematic review. Obes Rev.
  48. (2006). Effects of sibutramine treatment in obese adolescents: a randomized trial. Ann Intern Med.
  49. Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions.
  50. (2004). Emans SJ. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med.
  51. Establishing a standard definition for child overweight and obesity worldwide: international survey.
  52. Exercise alone reduces insulin resistance in obese children independently of changes in body composition.
  53. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report.
  54. (2007). Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study. Diabetes Care.
  55. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies
  56. Glycemic control with metformin or insulin therapy in adolescents with type 2 diabetes mellitus.
  57. (2008). Health-related quality of life of children and adolescents with type 1 or type 2 diabetes mellitus: SEARCH for Diabetes in Youth Study. Arch Pediatr Adolesc Med.
  58. High body mass index for age among US children and adolescents,
  59. Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study.
  60. (2005). Improvement of fitness, body composition, and insulin sensitivity in overweight children in a school-based exercise program: a randomized, controlled study. Arch Pediatr Adolesc Med.
  61. (1998). Increased incidence of non-insulin dependent diabetes mellitus among Japanese schoolchildren correlates with an increased intake of animal protein and fat. Clin Pediatr (Phila).
  62. (2006). Inflammation and changes in metabolic syndrome abnormalities
  63. Instability in the diagnosis of metabolic syndrome in adolescents.
  64. (1995). Insulin doses in children using conventional therapy for insulin dependent diabetes. Diabetes Res Clin Pract.
  65. (2009). Interventions for treating obesity in children. Cochrane Database Syst Rev.
  66. Laparoscopic adjustable gastric banding for the treatment of adolescent morbid obesity in the United States: a safe alternative to gastric bypass.
  67. (2006). Laparoscopic gastric banding in adolescents. Obes Surg.
  68. Lipid screening and cardiovascular health in childhood.
  69. Long-term effects of modest weight loss in type II diabetic patients.
  70. (1922). Long-term morbidity and mortality of overweight adolescents.
  71. Long-term mortality after gastric bypass surgery.
  72. (2009). Management and 1 year outcome for UK children with type 2 diabetes. Arch Dis Child.
  73. Measuring effectiveness of dietetic interventions in child obesity: a systematic review of randomized trials.
  74. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care.
  75. (2006). Metabolic syndrome – a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med.
  76. (2009). Metformin for obesity in children and adolescents: a systematic review. Diabetes Care.
  77. Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche.
  78. Metformin treatment to prevent early puberty in girls with precocious pubarche.
  79. (2005). Neuropsychiatric disorders at the presentation of type 2 diabetes mellitus in children. Pediatr Diabetes.
  80. New classification and criteria for diabetes: moving the goalposts closer.
  81. (2006). Nonalcoholic Fatty Liver Disease (NAFLD): Approach in the Adolescent Patient. Curr Treat Options Gastroenterol.
  82. Nutrient deficiencies secondary to bariatric surgery.
  83. Obesity and the metabolic syndrome in children and adolescents.
  84. Obesity in children and adolescents.
  85. Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
  86. (2009). Organization. World Health Statistics
  87. Orlistat treatment in obese prepubertal children: a pilot study.
  88. (2006). Parent reasons for nonreturn to a pediatric weight management program. Clin Pediatr (Phila).
  89. Perioperative outcomes of bariatric surgery in adolescents compared with adults at academic medical centers. Surg Obes Relat Dis.
  90. Predictors of metabolic control among adolescents with diabetes: a 4-year longitudinal study.
  91. (1999). Prevalence and trends in overweight among US children and adolescents,
  92. (2003). Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med.
  93. Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents. Arch Pediatr Adolesc Med.
  94. (2006). Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care.
  95. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention.
  96. Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion.
  97. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
  98. Progressive beta cell failure in type 2 diabetes mellitus of youth.
  99. (2009). Psychosocial functioning improves following adolescent bariatric surgery. Obesity (Silver Spring).
  100. Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome.
  101. Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin.
  102. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
  103. Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents.
  104. Rising incidence of type 2 diabetes in children in the U.K. Diabetes Care.
  105. Role of obesity in complicating and confusing the diagnosis and treatment of diabetes in children.
  106. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche.
  107. (2007). Serum lipids and glucose control: the SEARCH for Diabetes in Youth study. Arch Pediatr Adolesc Med.
  108. Service quality and attrition: An examination of a pediatric obesity program.
  109. Short-term insulin therapy in adolescents with type 2 diabetes mellitus.
  110. Systematic review and meta-analysis of bariatric surgery for pediatric obesity.
  111. The contribution of childhood obesity to adult carotid intima-media thickness: the Bogalusa Heart Study.
  112. The effect of sibutramine on energy expenditure and body composition in obese adolescents.
  113. (2001). The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics.
  114. (2005). The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents.
  115. The importance of beta-cell management in type 2 diabetes.
  116. The metabolic syndrome in children and adolescents.
  117. (2004). The metabolic syndrome in children and adolescents. Curr Diab Rep.
  118. (2004). The phantom of lactic acidosis due to metformin in patients with diabetes. Diabetes Care.
  119. (1999). The type 2 family: a setting for development and treatment of adolescent type 2 diabetes mellitus. Arch Pediatr Adolesc Med.
  120. (2002). Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obes Res.
  121. Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study.
  122. (2007). Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes.
  123. Type 1 and type 2 diabetes mellitus in childhood in the United States: practice patterns by pediatric endocrinologists.
  124. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity – a problem that is no longer restricted to minority groups.
  125. Type 2 diabetes mellitus in children and adolescents: a review from a European perspective. Horm Res.
  126. Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebocontrolled clinical trial.
  127. (2008). Variations of weight loss following gastric bypass and gastric band. Ann Surg.
  128. Vitamin D deficiency in adolescent females.
  129. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.